This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors.
Research into PRAME as an immunotherapy target in sarcoma subtypes. 13569.rar
Based on your request, "13569.rar" appears to be a file identifier, likely associated with scientific or medical research datasets. This research, likely part of the dataset, analyzed
Immune checkpoint inhibitors in sarcomas: a systematic review likely part of the dataset
Other related research topics often found in similar databases include:
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma